You are here: Industry Insights > FDA

News List

Good News in the Anti-AβAntibodies Field, Two Drugs were Successively Granted Breakthrough Drug Qualification by the FDA PharmaSources/Dopine
July 13, 2021
Two AD drugs have been granted BTD by the FDA recently, namely Eisai/Biogen's Lecanemab (BAN2401) and Eli Lilly's Donanemab.
Rare Disease Drug 101 - What are the Benefits to Apply for and Receive Orphan Drug Designation? Lin Zhang
June 29, 2021
There are many common diseases that affect millions of people across the world. On the other hand, there are so-called rare conditions that affect a small number of people.
New Development of FDA Regulations on Complex Generic Drugs PharmaSources/Zhulikou431
June 03, 2021
Since the promulgation of the Hatch-Waxman Act in 1984, in order to promote drug competition and improve public drug availability, FDA has formulated a number of policies aimed at accelerating the marketing of generic drugs.
What’s New on FDA Generic Drugs Forum 2021? LIN ZHANG
May 08, 2021
Once a year, the Generic Drugs Forum was held on April 28 - 29, 2021 by the FDA Office of Generic Drugs (OGD).
O-drug Approved as First-line Immunotherapy for Gastric Cancer and What Other Domestic Counterparts to Expect PharmaSources/Yefenghong
May 08, 2021
O-drug is the first approved immunotherapy for first-line treatment of gastric cancer.
Top Bulk Deflazacort Powder Manufacturers in China PharmaSources.com
April 13, 2021
Deflazacort (C25H31NO6) is a glucocorticoid that works as an immunosuppressant and anti-inflammatory. The FDA (Food and Drug Administration) considers it a first-class medication approved in 2017. Generally, it is a corticosteroid prodrug that can ...
Biosimilars 2020: Low Approvals, but Significant Advances Neeta Ratanghayra
March 18, 2021
2020 has been a tough year. The pandemic posed an array of challenges to the healthcare system and the global biopharmaceutical industry both rose to the challenges and seized opportunities.
FDA Orange Book 101 Lin Zhang
February 04, 2021
There are thousands of drugs out there, each with specific benefits, potential side effects, and possible interactions, with many of the drugs being equivalent to one another or serving as alternative treatments for the same issue.
Chinese-Produced Anticancer Drugs Granted Designations by the FDA PharmaSources/Xiaobin
February 08, 2021
As we wave goodbye to 2020 and embrace the arrival of 2021, it’s time for us to review, sum-up, and outlook.
Pharma and Health from Ingredients to Pills: Artificial Intelligence (AI) and Drug Development Lin Zhang
December 09, 2020
Artificial Intelligence (AI) is gaining traction across a variety of sectors. AI can be used for a variety of goals and is likely to become a staple in drug development, among other things.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 366 367 Next page